Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Xeris Biopharma Holdings, Inc. - Common Stock (NQ:XERS)

7.090 -0.260 (-3.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Xeris Biopharma Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 28.64% to $2.47 during Monday's pre-market session. The company's market cap stands at $38.1 million.... 
Via Benzinga
News headline image
Xeris Pharmaceuticals Enters Collaboration Agreement With Merck
From Xeris Biopharma Holdings, Inc.
Via Business Wire
News headline image
45 Biggest Movers From Yesterday ↗
Gainers Camber Energy, Inc.. (NYSE: CEI) shares surged 95.9% to close at $1.78 on Thursday after dipping over 40% on Wednesday. Camber Energy filed amended 8K showing financial... 
Via Benzinga
News headline image
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:... 
Via Benzinga
News headline image
Why Is Xeris Pharmaceuticals (XERS) Stock Shining On Monday ↗
The 
Via Benzinga
News headline image
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
News headline image
Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma
From Xeris Pharmaceuticals, Inc.
Via Business Wire
News headline image
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Xeris Pharmaceuticals, Inc.
Via Business Wire
News headline image
Xeris Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
From Xeris Pharmaceuticals, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers Xeris Pharmaceuticals (NASDAQ:XERS 
Via Benzinga
News headline image
Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharma
From Xeris Pharmaceuticals, Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Cardiff Oncology (NASDAQ: 
Via Benzinga
News headline image
Xeris Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
From Xeris Pharmaceuticals, Inc.
Via Business Wire
News headline image
Xeris Pharmaceuticals Completes Enrollment of Its Phase 1 Study of Levothyroxine (XP-8121)
From Xeris Pharmaceuticals, Inc.
Via Business Wire
News headline image
Xeris Pharmaceuticals Announces Leading Independent Proxy Advisory Firm, ISS, Recommends Xeris Stockholders Vote “FOR” the Transaction With Strongbridge Biopharma
From Xeris Pharmaceuticals, Inc.
Via Business Wire
News headline image
21 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on Tuesday. Regencell Bioscience recently reported... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
News headline image
Why Xeris Pharmaceuticals Shares Traded Higher Today ↗
Xeris Pharmaceuticals Inc (NASDAQ: XERS) is trading significantly higher Monday after the company announced U.S. Food and Drug Administration approval of its... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Vivos Therapeutics (NASDAQ:VVOS) stock rose 45.44% to $5.58 during Monday's regular session. As of 12:30 EST, Vivos Therapeutics's stock is trading at a... 
Via Benzinga
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,... 
Via Benzinga
News headline image
35 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value... 
Via Benzinga
News headline image
Xeris Pharmaceuticals Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke® Kit for the Treatment of Severe Hypoglycemia
From Xeris Pharmaceuticals, Inc.
Via Business Wire
News headline image
Xeris Pharmaceuticals Strengthens Its Patent Estate
From Xeris Pharmaceuticals, Inc.
Via Business Wire
News headline image
Xeris Pharmaceuticals Achieves Unprecedented Levels of Payor Coverage for Gvoke®
From Xeris Pharmaceuticals, Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Tuesday morning, 282 companies set new 52-week lows. Key Facts: Alibaba Group Holding (NYSE:BABA) was the biggest company by market cap to set a new 52-week low.... 
Via Benzinga
News headline image
54 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 64.2% to $2.0850 after the company announced it is expanding its blockchain business to engage in cryptocurrency... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.